{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:50:27Z","timestamp":1791654627286,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020872","name":"Tainan Municipal An Nan Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Executive Yuan Republic of China Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007404","name":"China Medical University Hospital Taichung Hospital Clinical Trial Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbi.2026.106922","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:41:07Z","timestamp":1785253267000},"page":"106922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications"],"prefix":"10.1016","volume":"138","author":[{"given":"Ayesha Zafar","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikbal Andrian","family":"Malau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet-Kei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Pei-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-2502","authenticated-orcid":false,"given":"Kuan-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106922_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113676","article-title":"The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice","volume":"418","author":"Aoki","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.bbi.2026.106922_b0015","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1194\/jlr.M045583","article-title":"Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation","volume":"55","author":"Barden","year":"2014","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.bbi.2026.106922_b0020","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.115.116384","article-title":"Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin","volume":"102","author":"Barden","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.bbi.2026.106922_b0025","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/s41380-021-01160-8","article-title":"Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis","volume":"26","author":"Borsini","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12967-020-02569-5","article-title":"Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in asample of adults with chronic pain","volume":"18","author":"Callan","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbi.2026.106922_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2019.09.022","article-title":"Nutrition and immunology in mental health: precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments","volume":"85","author":"Chang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106922_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107857","article-title":"Nutraceutical eicosapentaenoic acid in treatment-resistant depression: the psychoneuroimmunity and clinical implications","volume":"218","author":"Chang","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.bbi.2026.106922_b0045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00011-012-0489-8","article-title":"Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis","volume":"61","author":"Chiu","year":"2012","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.4049\/jimmunol.1201272","article-title":"Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat","volume":"189","author":"Cl\u00e0ria","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0055","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/nu17122014","article-title":"From fish oil to resolution: a narrative review on the potential of SPM-enriched marine oil for exercise-induced muscle damage recovery","volume":"17","author":"de Souza","year":"2025","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.bbi.2026.106922_b0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ijnp\/pyx023","article-title":"Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway","volume":"20","author":"Deyama","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jphs.2018.09.006","article-title":"Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice","volume":"138","author":"Deyama","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41398-025-03776-8","article-title":"Integrative neuroimmunology reveals leukocyte-expressing PAX6 as a critical predictor of major depressive disorder","volume":"16","author":"Dias","year":"2025","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2026.106922_b0075","first-page":"66","article-title":"Omega-3 polyunsaturated fatty acids in depression: insights from recent clinical trials","volume":"28","author":"Dyall","year":"2025","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"8","key":"10.1016\/j.bbi.2026.106922_b0080","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12882-021-02351-9","article-title":"Effect of omega-3 fatty acids supplementation on cardio-metabolic and oxidative stress parameters in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"22","author":"Fazelian","year":"2021","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","article-title":"Imaging the Role of Inflammation in Mood and Anxiety-related Disorders","volume":"16","author":"Felger","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8120376","article-title":"Modified lipids and lipoproteins in chronic kidney disease: a new class of uremic toxins","volume":"8","author":"Florens","year":"2016","journal-title":"Toxins (basel)"},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.75.1.57","article-title":"The STAR*D study: treating depression in the real world","volume":"75","author":"Gaynes","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"issue":"10","key":"10.1016\/j.bbi.2026.106922_b0110","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.3390\/jcm12103497","article-title":"Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"G\u0119dek","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbi.2026.106922_b0105","article-title":"Lipid metabolic dysregulation-induced neuroinflammation in the pathophysiology of major depressive disorder [Review]","volume":"16\u20132025","author":"Ge","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bbi.2026.106922_b0115","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3390\/md12115396","article-title":"Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression","volume":"12","author":"Gilbert","year":"2014","journal-title":"Mar. Drugs"},{"issue":"10","key":"10.1016\/j.bbi.2026.106922_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102221","article-title":"Pro-resolving inflammatory effects of a marine oil enriched in specialized pro-resolving mediators (SPMs) supplement and its implication in patients with post-COVID syndrome (PCS)","volume":"12","author":"Gracia Aznar","year":"2024","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.bbi.2026.106922_b0125","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002034","article-title":"Short-term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the Omega-PAD I Trial)","volume":"4","author":"Grenon","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000502652","article-title":"International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder","volume":"88","author":"Guu","year":"2019","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.bbi.2026.106922_b0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2020.01.050","article-title":"A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder","volume":"265","author":"Guu","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2026.106922_b0140","doi-asserted-by":"crossref","DOI":"10.1101\/2025.04.04.25325253","article-title":"Associations of plasma omega-3 fatty acid levels and reported fish oil supplement use with depression and anxiety: a cross-sectional analysis from the UK Biobank","author":"Harris","year":"2025","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbi.2026.106922_b0145","unstructured":"Health, N. I. o. (2019). Omega-3 fatty acids: fact sheet for health professionals. In."},{"issue":"6","key":"10.1016\/j.bbi.2026.106922_b0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1113\/jphysiol.2013.267336","article-title":"Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle","volume":"592","author":"Herbst","year":"2014","journal-title":"J. Physiol."},{"issue":"19","key":"10.1016\/j.bbi.2026.106922_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/nu15194231","article-title":"Effects of omega-3 polyunsaturated fatty acids intake on vasomotor symptoms, sleep quality and depression in postmenopausal women: a systematic review","volume":"15","author":"Iqbal","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2026.106922_b0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbr.2017.06.010","article-title":"Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model","volume":"332","author":"Ishikawa","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbi.2026.106922_b0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/REP-14-0549","article-title":"Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors","volume":"149","author":"Keelan","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.bbi.2026.106922_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0175","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2026.106922_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102219","article-title":"Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation","volume":"164","author":"Lamon-Fava","year":"2021","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"issue":"6","key":"10.1016\/j.bbi.2026.106922_b0180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41386-022-01527-7","article-title":"Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators","volume":"48","author":"Lamon-Fava","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbi.2026.106922_b0190","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00210-022-02274-8","article-title":"Resolvin D5 disrupts anxious-and depressive-like behaviors in a type 1 diabetes mellitus animal model","volume":"395","author":"Le\u00e3o","year":"2022","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0195","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1186\/s12888-023-05358-8","article-title":"Association between mitochondrial DNA levels and depression: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2026.106922_b0205","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41582-025-01116-4","article-title":"Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder","volume":"21","author":"Maes","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"21","key":"10.1016\/j.bbi.2026.106922_b0210","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cells13211791","article-title":"Omega-3 fatty acids and neuroinflammation in depression: targeting damage-associated molecular patterns and neural biomarkers","volume":"13","author":"Malau","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106922_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2023.102542","article-title":"Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis","volume":"190","author":"Marchand","year":"2023","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"11","key":"10.1016\/j.bbi.2026.106922_b0220","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1096\/fj.201600360R","article-title":"Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid","volume":"30","author":"Markworth","year":"2016","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbi.2026.106922_b0225","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0235","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1038\/s41598-026-44339-1","article-title":"Improved muscle recovery after omega-3 supplementation is associated with increased oxylipin availability","volume":"16","author":"Miranda-Fuentes","year":"2026","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0240","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12967-023-04283-4","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study","volume":"21","author":"M\u00f6ller","year":"2023","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbi.2026.106922_b0245","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/db12-0828","article-title":"Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation","volume":"62","author":"Neuhofer","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0250","first-page":"e3868","article-title":"Evaluation of serum interleukin-6 and C-reactive protein levels in drug-na\u00efve major depressive disorder patients","volume":"11","author":"Nishuty","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.bbi.2026.106922_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36679-4","article-title":"Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation","volume":"8","author":"Norris","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106922_b0260","doi-asserted-by":"crossref","unstructured":"Pasman, J. A., et al. (2024). Causes and consequences of major depressive disorder: An encompassing Mendelian randomization study. medRxiv. https:\/\/doi.org\/https:\/\/doi.org\/10.1101\/2024.05.21.24307678.","DOI":"10.2139\/ssrn.4837562"},{"issue":"2","key":"10.1016\/j.bbi.2026.106922_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016957","article-title":"The human serum metabolome","volume":"6","author":"Psychogios","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106922_b0270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","article-title":"Fish Oil increases specialized pro-resolving lipid mediators in PAD (the OMEGA-PAD II Trial)","volume":"238","author":"Ramirez","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbi.2026.106922_b0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbi.2015.12.013","article-title":"Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro","volume":"55","author":"Rey","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2026.106922_b0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1176\/ajp.2007.164.2.201","article-title":"STAR*D: what have we learned?","volume":"164","author":"Rush","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0285","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jacl.2017.06.011","article-title":"Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements","volume":"11","author":"Schaller","year":"2017","journal-title":"J. Clin. Lipidol."},{"issue":"15","key":"10.1016\/j.bbi.2026.106922_b0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016113","article-title":"Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy patients and those with peripheral artery disease","volume":"9","author":"Schaller","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0295","doi-asserted-by":"crossref","first-page":"20128","DOI":"10.1038\/s41598-020-75353-6","article-title":"The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery","volume":"10","author":"Schulte","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bbi.2026.106922_b0300","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1073\/pnas.86.8.2903","article-title":"Membrane docosahexaenoate is supplied to the developing brain and retina by the liver","volume":"86","author":"Scott","year":"1989","journal-title":"PNAS"},{"key":"10.1016\/j.bbi.2026.106922_b0305","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.plefa.2017.08.008","article-title":"Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: a double blind, randomized controlled clinical trial","volume":"126","author":"See","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"11","key":"10.1016\/j.bbi.2026.106922_b0310","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1017\/S0007114517002914","article-title":"Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial","volume":"118","author":"See","year":"2017","journal-title":"Br. J. Nutr."},{"issue":"7","key":"10.1016\/j.bbi.2026.106922_b0320","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bbi.2026.106922_b0315","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2026.106922_b0325","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jad.2023.02.016","article-title":"Maresin-1 improves LPS-induced depressive-like behavior by inhibiting hippocampal microglial activation","volume":"328","author":"Shi","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bbi.2026.106922_b0330","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1194\/jlr.M060392","article-title":"Bioactive products formed in humans from fish oils","volume":"56","author":"Skarke","year":"2015","journal-title":"J. Lipid Res."},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0335","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","article-title":"Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: a Science Advisory from the American Heart Association","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbi.2026.106922_b0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plipres.2015.12.003","article-title":"The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: acting separately or synergistically?","volume":"62","author":"Song","year":"2016","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","article-title":"Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study","volume":"126","author":"Souza","year":"2020","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bbi.2026.106922_b0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/YCO.0000000000000986","article-title":"Harmonizing the inner orchestra: the impact of urbanization and evolution of stress, inflammation, diet, and lifestyles in depression","volume":"38","author":"Su","year":"2025","journal-title":"Curr. Opin. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0355","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/13543784.2013.836487","article-title":"Omega-3 polyunsaturated fatty acids for major depressive disorder","volume":"22","author":"Su","year":"2013","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0365","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.2327","article-title":"Association of use of omega-3 polyunsaturated fatty acids with changes in severity of anxiety symptoms: a systematic review and meta-analysis","volume":"1","author":"Su","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbi.2026.106922_b0350","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbi.2019.04.032","article-title":"Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder","volume":"80","author":"Su","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2026.106922_b0370","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2026.106922_b0375","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.plipres.2004.05.004","article-title":"Omega-3 fatty acids in cellular membranes: a unified concept","volume":"43","author":"Valentine","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbi.2026.106922_b0380","unstructured":"W\u00e4chter, S. F. (2012). Effects of omega-3 fatty acids docosahexaenoic acid and eicosapentaenoic acid and their metabolites in acute inflammation."},{"key":"10.1016\/j.bbi.2026.106922_b0385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jpsychires.2025.01.020","article-title":"Investigating the impact of omega-3 fatty acids on oxidative stress and pro-inflammatory cytokine release in iPSC-derived forebrain cortical neurons from ADHD patients","volume":"182","author":"Walter","year":"2025","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2026.106922_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111028","article-title":"Early evidence of beneficial and protective effects of Protectin DX treatment on behavior responses and type-1 diabetes mellitus related-parameters: a non-clinical approach","volume":"133","author":"Waltrick","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.bbi.2026.106922_b0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2012.01.005","article-title":"Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation","volume":"97","author":"Weylandt","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"12","key":"10.1016\/j.bbi.2026.106922_b0400","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.2337\/db10-0054","article-title":"Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat\u2013fed mice","volume":"59","author":"White","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bbi.2026.106922_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13061003","article-title":"Personalized medicine of omega-3 fatty acids in depression treatment in obese and metabolically dysregulated patients","volume":"13","author":"Wu","year":"2023","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.bbi.2026.106922_b0410","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s10787-023-01234-9","article-title":"Resolvin D1 attenuates depressive-like behavior in LPS-challenged mice by promoting microglial autophagy","volume":"31","author":"Xiong","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbi.2026.106922_b0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2019.05.033","article-title":"Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of \u03b2-Amyloid in a mouse model with Alzheimer's disease","volume":"85","author":"Yan","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106922_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101196","article-title":"Comparative efficacy of omega-3 polyunsaturated fatty acids on major cardiovascular events: a network meta-analysis of randomized controlled trials","volume":"88","author":"Yang","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbi.2026.106922_b0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbi.2022.04.001","article-title":"Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19","volume":"103","author":"Yang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106922_b0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2024.07.016","article-title":"Refining the understanding of EPA's role in episodic migraine: a response to methodological considerations","volume":"121","author":"Yang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106922_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115947","article-title":"Addressing methodological concerns in omega-3 trial for bipolar disorder relapse prevention","volume":"337","author":"Zailani","year":"2024","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.bbi.2026.106922_b0440","doi-asserted-by":"crossref","first-page":"349","DOI":"10.59249\/YZLQ4631","article-title":"Omega-3 polyunsaturated fatty acids and blood-brain barrier integrity in major depressive disorder: restoring balance for neuroinflammation and neuroprotection","volume":"97","author":"Zailani","year":"2024","journal-title":"Yale J. Biol. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:32:42Z","timestamp":1791653562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126006707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":88,"alternative-id":["S0889159126006707"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106922","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106922"}}